David Franklin Kong | Scholars@Duke

David Franklin Kong
Associate Professor of Medicine

David F. Kong, M.D., A.M., D.M.T., F.A.C.C., F.S.C.A.I. is an Associate Professor of Medicine at Duke University Medical Center and Co-Director of the Cardiovascular Late Phase 3 and Devices Unit at the Duke Clinical Research Institute. An interventional cardiologist at Duke Hospital and a faculty member in the Duke Center for Healthcare Informatics, Dr. Kong specializes in cardiovascular informatics research and integration of evidence from cardiovascular clinical trials. Dr. Kong graduated magna cum laude from HarvardUniversity, where he also received a master’s degree in Organismic and Evolutionary Biology. He received his medical degree from the Johns Hopkins University School of Medicine, and was a resident on the Osler Medical Service at the JohnsHopkinsHospital. He completed fellowships in Cardiovascular Disease and Interventional Cardiovascular Medicine at DukeUniversity before joining the Duke faculty. Dr. Kong is board certified in internal medicine, cardiology, and interventional cardiology. He is a Certified Diver Medic, Master Diver, and Dive Medical Examiner, and has been elected Fellow of the American College of Cardiology and the Society for Cardiovascular Angiography and Interventions.

Current Appointments & Affiliations

Associate Professor of Medicine, Medicine, Cardiology, Medicine 2011
Member in the Duke Clinical Research Institute, Duke Clinical Research Institute, Institutes and Centers 1996

Contact Information

Duke Box 3850, Durham, NC 27710
North Pavilion 7069, 2400 Pratt St, Durham, NC 27705
kong0008@dcri.duke.edu (919) 668-8946

Background
Education, Training, & Certifications
- Fellow in Cardiology, Medicine, Duke University 1995 - 2001
- Medical Resident, Medicine, Johns Hopkins University 1993 - 1995
- M.D., Johns Hopkins University 1993
Duke Appointment History
- Assistant Professor of Medicine, Medicine, Cardiology, Medicine 2010 - 2011
- Assistant Professor of Medicine, Medicine, Cardiology, Medicine 2002 - 2010
- Associate in the Department of Medicine, Medicine, Cardiology, Medicine 2001 - 2002
- Instructor, Temporary in the Department of Medicine, Medicine, Cardiology, Medicine 2001
Research
Selected Grants
- SAFE STEMI in Seniors LOI for Volcano 2016 - 2021
- HARMONEE 2014 - 2020
- MEDpiNET awarded by Food and Drug Administration 2013 - 2017
- BRIDGE DCC awarded by National Institutes of Health 2008 - 2017
- Standardized Collection and Submission of Cardiovascular Endpoint Data awarded by Food and Drug Administration 2012 - 2013
- Data Concepts and Terminology Standards in Cardiovascular Imaging (R24) awarded by Food and Drug Administration 2012 - 2013
- Thrombosis and Hemostasis Centers Research and Prevention Network 2002 - 2013
- ACC/Duke Partnership for a National Cardiovascular Research Infrastructure (NCRI) awarded by National Institutes of Health 2009 - 2012
- Rare Thrombotic Diseases Clinical Research Network awarded by National Institutes of Health 2004 - 2010
- Collaborative Research....LT Outcomes of Stents in Coronary Interventions awarded by Agency for Healthcare Research and Quality 2008 - 2009
- Treatment of In-Stent Restenosis awarded by Agency for Healthcare Research and Quality 2005 - 2007
- Predoctoral Clinical Research Training Program awarded by National Institutes of Health 2005 - 2006
Industry Relationships
- Allmed Healthcare
- Chiesi USA
- Faculty Connection
- International Business Machines Corp.
- OrbusNeich
Publications & Artistic Works
Selected Publications
- Academic Articles
  - Oka, Hiroshi, Kenji Miki, Iwao Kishita, David F. Kong, and Takahiro Uchida. “A Multicenter, Prospective, Randomized, Placebo-Controlled, Double-Blind Study of a Novel Pain Management Device, AT-02, in Patients with Fibromyalgia..” Pain Med, June 5, 2019. https://doi.org/10.1093/pm/pnz064.
    Full Text Link to Item
  - Fanaroff, Alexander C., Robert Clare, Karen S. Pieper, Kenneth W. Mahaffey, Chiara Melloni, Jennifer B. Green, John H. Alexander, et al. “Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 Trials..” Circulation 139, no. 7 (February 12, 2019): 863–73. https://doi.org/10.1161/CIRCULATIONAHA.118.037202.
    Full Text Link to Item
  - Eisenstein, Eric L., Daniel Wojdyla, and David F. Kong. “Estimating Clinical Trial Bleeding Events Using Electronic Health Record Data..” Stud Health Technol Inform 257 (2019): 92–97.
    Link to Item
  - Fudim, Marat, Arun Ganesh, Cindy Green, W Schuyler Jones, Michael A. Blazing, Adam D. DeVore, G Michael Felker, et al. “Splanchnic nerve block for decompensated chronic heart failure: splanchnic-HF..” Eur Heart J 39, no. 48 (December 21, 2018): 4255–56. https://doi.org/10.1093/eurheartj/ehy682.
    Full Text Link to Item
  - Artzner, Christoph, Melissa Daubert, Wendy Ehieli, David Kong, Joseph Mammarappallil, Konstantin Nikolaou, Daniel T. Boll, and Lynne Koweek. “Impact of computed tomography (CT)-derived fractional flow reserve on reader confidence for interpretation of coronary CT angiography..” Eur J Radiol 108 (November 2018): 242–48. https://doi.org/10.1016/j.ejrad.2018.09.035.
    Full Text Link to Item
  - Hernandez, Adrian F., Jennifer B. Green, Salim Janmohamed, Ralph B. D’Agostino, Christopher B. Granger, Nigel P. Jones, Lawrence A. Leiter, et al. “Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial..” Lancet 392, no. 10157 (October 27, 2018): 1519–29. https://doi.org/10.1016/S0140-6736(18)32261-X.
    Full Text Link to Item
  - Saito, Shigeru, Mitchell W. Krucoff, Shigeru Nakamura, Roxana Mehran, Akiko Maehara, Hussein R. Al-Khalidi, Stephen M. Rowland, et al. “Japan-United States of America Harmonized Assessment by Randomized Multicentre Study of OrbusNEich's Combo StEnt (Japan-USA HARMONEE) study: primary results of the pivotal registration study of combined endothelial progenitor cell capture and drug-eluting stent in patients with ischaemic coronary disease and non-ST-elevation acute coronary syndrome..” Eur Heart J 39, no. 26 (July 7, 2018): 2460–68. https://doi.org/10.1093/eurheartj/ehy275.
    Full Text Link to Item
  - Barac, Yaron D., Hazim Alwair, David F. Kong, Chetan B. Patel, Mani A. Daneshmand, Carmelo A. Milano, and Jacob N. Schroder. “Migration of Intraaortic Balloon Pump Placed Via the Axillary Artery..” J Invasive Cardiol 30, no. 1 (January 2018).
    Link to Item
  - Kong, David F., Shigeru Saito, Shigeru Nakamura, Roxana Mehran, Stephen M. Rowland, Allison Handler, Hussein R. Al-Khalidi, and Mitchell W. Krucoff. “Rationale and design of the Japan-USA harmonized assessment by randomized, multicenter study of OrbusNEich's combo StEnt (Japan-USA HARMONEE): Assessment of a novel DES platform for percutaneous coronary revascularization in patients with ischemic coronary disease and non-ST-elevation acute coronary syndrome..” Am Heart J 187 (May 2017): 112–21. https://doi.org/10.1016/j.ahj.2017.02.004.
    Full Text Link to Item
  - Welsby, I. J., E. F. Krakow, J. A. Heit, E. C. Williams, G. M. Arepally, S. Bar-Yosef, D. F. Kong, et al. “The association of anti-platelet factor 4/heparin antibodies with early and delayed thromboembolism after cardiac surgery..” J Thromb Haemost 15, no. 1 (January 2017): 57–65. https://doi.org/10.1111/jth.13533.
    Full Text Link to Item
  - Kong, David F., and E Magnus Ohman. “Chronic Total Coronary Occlusions, Percutaneous Coronary Intervention, and Mortality: A "Hybrid Approach" to Interpretation..” Jacc Cardiovasc Interv 9, no. 15 (August 8, 2016): 1545–47. https://doi.org/10.1016/j.jcin.2016.06.009.
    Full Text Link to Item
  - Partin, Melissa R., Aasma Shaukat, David B. Nelson, Amy Gravely, Sean Nugent, Ziad F. Gellad, and James F. Burgess. “Reply..” Clin Gastroenterol Hepatol 14, no. 3 (March 2016). https://doi.org/10.1016/j.cgh.2015.12.008.
    Full Text Link to Item
  - Zeitler, Emily P., Sana M. Al-Khatib, Joseph P. Drozda, Larry G. Kessler, Ajay J. Kirtane, David F. Kong, John Laschinger, et al. “Predictable and SuStainable Implementation of National Cardiovascular Registries (PASSION) infrastructure: A think tank report from Medical Device Epidemiological Network Initiative (MDEpiNet)..” Am Heart J 171, no. 1 (January 2016). https://doi.org/10.1016/j.ahj.2015.07.029.
    Full Text Link to Item
  - Zeitler, Emily P., Sana M. Al-Khatib, Joseph P. Drozda, Larry G. Kessler, Ajay J. Kirtane, David F. Kong, John Laschinger, et al. “Predictable and Su Stainable Implementation of National Cardiovascular Registries (PASSION) infrastructure: A think tank report from Medical Device Epidemiological Network Initiative (MDEpiNet).” American Heart Journal 171, no. 1 (January 1, 2016): 64–72. https://doi.org/10.1016/j.ahj.42015.07.029.
    Full Text Link to Item
  - Douketis, James D., Alex C. Spyropoulos, Scott Kaatz, Richard C. Becker, Joseph A. Caprini, Andrew S. Dunn, David A. Garcia, et al. “Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation..” N Engl J Med 373, no. 9 (August 27, 2015): 823–33. https://doi.org/10.1056/NEJMoa1501035.
    Full Text Link to Item
  - Hess, Connie N., Matthew T. Roe, Robert M. Clare, Karen Chiswell, Joseph Kelly, James E. Tcheng, Emil Hagstrom, et al. “Relationship Between Cancer and Cardiovascular Outcomes Following Percutaneous Coronary Intervention..” J Am Heart Assoc 4, no. 7 (July 6, 2015). https://doi.org/10.1161/JAHA.115.001779.
    Full Text Open Access Copy Link to Item
  - Rao, Sunil V., Connie N. Hess, Britt Barham, Laura H. Aberle, Kevin J. Anstrom, Tejan B. Patel, Jesse P. Jorgensen, et al. “A registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention: the SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women) trial..” Jacc Cardiovasc Interv 7, no. 8 (August 2014): 857–67. https://doi.org/10.1016/j.jcin.2014.04.007.
    Full Text Link to Item
  - Al-Khatib, Sana M., Nancy M. Allen LaPointe, Ranee Chatterjee, Matthew J. Crowley, Matthew E. Dupre, David F. Kong, Renato D. Lopes, et al. “Rate- and rhythm-control therapies in patients with atrial fibrillation: a systematic review..” Ann Intern Med 160, no. 11 (June 3, 2014): 760–73. https://doi.org/10.7326/M13-1467.
    Full Text Link to Item
  - Alhejily, Wesam A., David F. Kong, and E. Magnus Ohman. “Retrograde approach to coronary chronic total occlusion via an occluded saphenous bypass graft: a case report..” Clin Case Rep 1, no. 2 (December 2013): 54–58. https://doi.org/10.1002/ccr3.23.
    Full Text Link to Item
  - Alexander, Karen P., David F. Kong, Aijing Z. Starr, Judith Kramer, Karen Chiswell, Asba Tasneem, and Robert M. Califf. “Portfolio of clinical research in adult cardiovascular disease as reflected in ClinicalTrials.gov..” J Am Heart Assoc 2, no. 5 (September 26, 2013). https://doi.org/10.1161/JAHA.113.000009.
    Full Text Open Access Copy Link to Item
  - Hess, Connie N., Sunil V. Rao, David F. Kong, Laura H. Aberle, Kevin J. Anstrom, C Michael Gibson, Ian C. Gilchrist, et al. “Embedding a randomized clinical trial into an ongoing registry infrastructure: unique opportunities for efficiency in design of the Study of Access site For Enhancement of Percutaneous Coronary Intervention for Women (SAFE-PCI for Women)..” Am Heart J 166, no. 3 (September 2013): 421–28. https://doi.org/10.1016/j.ahj.2013.06.013.
    Full Text Link to Item
  - Hess, Connie N., Sunil V. Rao, David F. Kong, Julie M. Miller, Kevin J. Anstrom, Olivier F. Bertrand, Jean-Philippe Collet, et al. “TransRadial Education and Therapeutics (TREAT): shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: a report from the Cardiac Safety Research Consortium..” Am Heart J 165, no. 3 (March 2013): 344-53.e1. https://doi.org/10.1016/j.ahj.2012.09.008.
    Full Text Link to Item
  - Roe, Matthew T., Paul W. Armstrong, Keith A. A. Fox, Harvey D. White, Dorairaj Prabhakaran, Shaun G. Goodman, Jan H. Cornel, et al. “Prasugrel versus clopidogrel for acute coronary syndromes without revascularization..” N Engl J Med 367, no. 14 (October 4, 2012): 1297–1309. https://doi.org/10.1056/NEJMoa1205512.
    Full Text Link to Item
  - Kong, D. F., and R. A. Harrington. “New drug development: Antihypertensives,” September 1, 2012, 33–40. https://doi.org/10.1016/B978-1-4557-0101-8.00002-3.
    Full Text
  - Eisenstein, Eric L., David F. Kong, Patricia A. Cowper, Jay P. Bae, Krishnan Ramaswamy, and Kevin J. Anstrom. “Nonfatal myocardial infarction and long-term outcomes in coronary artery disease..” Am Heart J 163, no. 1 (January 2012): 95–103. https://doi.org/10.1016/j.ahj.2011.09.024.
    Full Text Link to Item
  - Tricoci, Pierluigi, L Kristin Newby, Vic Hasselblad, David F. Kong, Robert P. Giugliano, Harvey D. White, Pierre Théroux, et al. “Upstream use of small-molecule glycoprotein iib/iiia inhibitors in patients with non-ST-segment elevation acute coronary syndromes: a systematic overview of randomized clinical trials..” Circ Cardiovasc Qual Outcomes 4, no. 4 (July 2011): 448–58. https://doi.org/10.1161/CIRCOUTCOMES.110.960294.
    Full Text Link to Item
  - Piccini, Jonathan P., and David F. Kong. “Mixed treatment comparisons for atrial fibrillation: evidence network or bewildering entanglement?.” Europace 13, no. 3 (March 2011): 295–96. https://doi.org/10.1093/europace/eur029.
    Full Text Link to Item
  - Whitlatch, Nicole L., David F. Kong, Ara D. Metjian, Gowthami M. Arepally, and Thomas L. Ortel. “Validation of the high-dose heparin confirmatory step for the diagnosis of heparin-induced thrombocytopenia..” Blood 116, no. 10 (September 9, 2010): 1761–66. https://doi.org/10.1182/blood-2010-01-262659.
    Full Text Link to Item
  - “Correction.” Journal of the American College of Cardiology 55, no. 19 (May 2010): 2185–2185. https://doi.org/10.1016/j.jacc.2010.03.022.
    Full Text
  - Kong, David F., Vic Hasselblad, and Mitchell W. Krucoff. “Evidence strength in FDA premarket approval of cardiovascular devices..” Jama 303, no. 16 (April 28, 2010): 1599–1600. https://doi.org/10.1001/jama.2010.511.
    Full Text Link to Item
  - Mark, Daniel B., and David F. Kong. “Cardiac computed tomographic angiography what's the prognosis?.” J Am Coll Cardiol 55, no. 10 (March 9, 2010): 1029–31. https://doi.org/10.1016/j.jacc.2009.11.048.
    Full Text Link to Item
  - Piccini, J. P., and D. F. Kong. “Reply.” Journal of the American College of Cardiology 55, no. 10 (March 9, 2010): 1052–53. https://doi.org/10.1016/j.jacc.2009.12.011.
    Full Text
  - Eisenstein, Eric L., Martin B. Leon, David E. Kandzari, Laura Mauri, Rex Edwards, David F. Kong, Patricia A. Cowper, Kevin J. Anstrom, and Kevin J. ENDEAVOR III Investigators. “Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)..” Jacc Cardiovasc Interv 2, no. 12 (December 2009): 1199–1207. https://doi.org/10.1016/j.jcin.2009.10.009.
    Full Text Link to Item
  - Eisenstein, Eric L., William Wijns, Jean Fajadet, Laura Mauri, Rex Edwards, Patricia A. Cowper, David F. Kong, and Kevin J. Anstrom. “Long-term clinical and economic analysis of the Endeavor drug-eluting stent versus the Driver bare-metal stent: 4-year results from the ENDEAVOR II trial (Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions)..” Jacc Cardiovasc Interv 2, no. 12 (December 2009): 1178–87. https://doi.org/10.1016/j.jcin.2009.10.011.
    Full Text Link to Item
  - Piccini, Jonathan P., Vic Hasselblad, Eric D. Peterson, Jeffrey B. Washam, Robert M. Califf, and David F. Kong. “Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation..” J Am Coll Cardiol 54, no. 12 (September 15, 2009): 1089–95. https://doi.org/10.1016/j.jacc.2009.04.085.
    Full Text Link to Item
  - Chan, Mark Y., Jie L. Sun, L Kristin Newby, Linda K. Shaw, Min Lin, Eric D. Peterson, Robert M. Califf, David F. Kong, and Matthew T. Roe. “Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction..” Circulation 119, no. 24 (June 23, 2009): 3110–17. https://doi.org/10.1161/CIRCULATIONAHA.108.799981.
    Full Text Link to Item
  - Douglas, Pamela S., J Matthew Brennan, Kevin J. Anstrom, Art Sedrakyan, Eric L. Eisenstein, Ghazala Haque, David Dai, et al. “Clinical effectiveness of coronary stents in elderly persons: results from 262,700 Medicare patients in the American College of Cardiology-National Cardiovascular Data Registry..” J Am Coll Cardiol 53, no. 18 (May 5, 2009): 1629–41. https://doi.org/10.1016/j.jacc.2009.03.005.
    Full Text Link to Item
  - Eisenstein, E. L., M. B. Leon, D. E. Kandzari, R. Edwards, P. A. Cowper, D. F. Kong, M. D. Silverstein, D. B. Mark, and K. J. Anstrom. “ECONOMIC ANALYSIS OF ENDEAVOR VS. CYPHER STENTS: RESULTS FROM THE ENDEAVOR III TRIAL.” Value in Health 12, no. 3 (May 1, 2009): A152–A152.
    Link to Item
  - Eisenstein, E. L., R. Edwards, P. A. Cowper, D. F. Kong, M. D. Silverstein, D. B. Mark, K. J. Anstrom, and W. Wijns. “ECONOMIC ANALYSIS OF THE ENDEAVOR DRUG-ELUTING STENT VS. THE DRIVER BARE METAL STENT: RESULTS FROM THE ENDEAVOR II TRIAL.” Value in Health 12, no. 3 (May 1, 2009): A152–A152.
    Link to Item
  - Brennan, J Matthew, Kevin J. Anstrom, Eric L. Eisenstein, David Dai, Ghazala Haque, David F. Kong, Ralph G. Brindis, et al. “Long-Term Outcomes of Drug-Eluting Versus Bare-Metal Stents in Underrepresented Populations: Results From the Linked NCDR and CMS Database.” Journal of the American College of Cardiology 53, no. 10 (March 10, 2009): A386–A386.
    Link to Item
  - Douglas, Pamela S., J Matthew Brennan, Kevin Anstrom, Eric L. Eisenstein, David Dai, Ghazala Haque, David F. Kong, et al. “Outcomes Following Coronary Stenting in a Linked NCDR and CMS Database: A National Study of Long-Term, Real World Outcomes of Bare Metal and Drug-Eluting Stents.” Journal of the American College of Cardiology 53, no. 10 (March 10, 2009): A401–2.
    Link to Item
  - Eisenstein, E. L., P. A. Cowper, J. P. Bae, D. F. Kong, K. Ramaswamy, and K. J. Anstrom. “CV1 WHAT IS THE CLINICAL BENEFIT OF PREVENTING NON-FATAL MYOCARDIAL INFARCTIONS?.” Value in Health 11, no. 6 (November 2008): A341–42. https://doi.org/10.1016/s1098-3015(10)66185-2.
    Full Text
  - Chan, Mark, Lena J. Sun, L. K. Newby, Linda K. Shaw, Eric D. Peterson, David F. Kong, Min Lin, Robert M. Califf, and Matthew T. Roe. “Long-Term Prognostic Impact of ST-elevation vs. Non-ST-elevation Myocardial Infarction.” Circulation 118, no. 18 (October 28, 2008): S1058–S1058.
    Link to Item
  - Anstrom, Kevin J., David F. Kong, Linda K. Shaw, Robert M. Califf, Judith M. Kramer, Eric D. Peterson, Sunil V. Rao, et al. “Long-term clinical outcomes following coronary stenting..” Arch Intern Med 168, no. 15 (August 11, 2008): 1647–55. https://doi.org/10.1001/archinte.168.15.1647.
    Full Text Link to Item
  - Kong, David F., Eric L. Eisenstein, and Robert Harrington. “Late adverse events after drug-eluting stent implantation..” Curr Cardiol Rep 10, no. 4 (July 2008): 253–62.
    Link to Item
  - Liao, L., D. F. Kong, Z. Samad, P. A. Pappas, J. G. Jollis, S. S. Lin, A. Wang, et al. “Echocardiographic risk stratification for early surgery with endocarditis: a cost-effectiveness analysis..” Heart 94, no. 5 (May 2008). https://doi.org/10.1136/hrt.2006.106716.
    Full Text Link to Item
  - Konstance, Richard P., Eric L. Eisenstein, Kevin J. Anstrom, Linda K. Shaw, Robert M. Califf, Robert A. Harrington, David B. Matchar, Kevin A. Schulman, and David F. Kong. “Outcomes of second revascularization procedures after stent implantation..” J Med Syst 32, no. 2 (April 2008): 177–86. https://doi.org/10.1007/s10916-007-9120-x.
    Full Text Link to Item
  - Eisenstein, Eric L., David F. Kong, Kevin J. Anstrom, and Robert M. Califf. “Clopidogrel and Long-term Outcomes After Drug-Eluting Stent Implantation—Reply.” Jama 297, no. 16 (April 25, 2007): 1769–1769. https://doi.org/10.1001/jama.297.16.1770-c.
    Full Text
  - Murasato, Yoshinobu, and Kyoko Okamatsu. “In-stent pseudo-restenosis due to an organized thrombus six months after implantation of a sirolimus-eluting stent..” J Invasive Cardiol 19, no. 3 (March 2007): 145–48.
    Link to Item
  - Eisenstein, Eric L., Kevin J. Anstrom, David F. Kong, Linda K. Shaw, Robert H. Tuttle, Daniel B. Mark, Judith M. Kramer, et al. “Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation..” Jama 297, no. 2 (January 10, 2007): 159–68. https://doi.org/10.1001/jama.297.2.joc60179.
    Full Text Link to Item
  - APEX AMI Investigators, Frans, Paul W. Armstrong, Christopher B. Granger, Peter X. Adams, Christian Hamm, David Holmes, William W. O’Neill, Thomas G. Todaro, Alec Vahanian, and Frans Van de Werf. “Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial..” Jama 297, no. 1 (January 3, 2007): 43–51. https://doi.org/10.1001/jama.297.1.43.
    Full Text Link to Item
  - Eisenstein, E. L., R. H. Tuttle, L. K. Shaw, K. J. Anstrom, and D. F. Kong. “PCV5 DRUG-ELUTING STENT USE IS ASSOCIATED WITH SIGNIFICANT IMPROVEMENTS IN LONG-TERM CLINICAL OUTCOMES.” Value in Health 9, no. 6 (November 2006): A338–A338. https://doi.org/10.1016/s1098-3015(10)63622-4.
    Full Text
  - Kachhy, Radha G., David F. Kong, Emily Honeycutt, Linda K. Shaw, and R Duane Davis. “Long-term outcomes of the symmetry vein graft anastomosis device: a matched case-control analysis..” Circulation 114, no. 1 Suppl (July 4, 2006): I425–29. https://doi.org/10.1161/CIRCULATIONAHA.105.000695.
    Full Text Link to Item
  - Halabi, Abdul R., John H. Alexander, Linda K. Shaw, Todd J. Lorenz, Lawrence Liao, David F. Kong, Carmelo A. Milano, Robert A. Harrington, and Peter K. Smith. “Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery..” Am J Cardiol 96, no. 9 (November 1, 2005): 1254–59. https://doi.org/10.1016/j.amjcard.2005.06.067.
    Full Text Link to Item
  - Liao, Lawrence, David F. Kong, Linda K. Shaw, Michael H. Sketch, Carmelo A. Milano, Kerry L. Lee, and Daniel B. Mark. “A new anatomic score for prognosis after cardiac catheterization in patients with previous bypass surgery..” J Am Coll Cardiol 46, no. 9 (November 1, 2005): 1684–92. https://doi.org/10.1016/j.jacc.2005.06.074.
    Full Text Link to Item
  - Savonitto, Stefano, Mauricio G. Cohen, Alessandro Politi, Michael P. Hudson, David F. Kong, Yao Huang, Karen S. Pieper, et al. “Extent of ST-segment depression and cardiac events in non-ST-segment elevation acute coronary syndromes..” Eur Heart J 26, no. 20 (October 2005): 2106–13. https://doi.org/10.1093/eurheartj/ehi395.
    Full Text Link to Item
  - Eisenstein, Eric L., Darren K. McGuire, Manjushri V. Bhapkar, Arni Kristinsson, Judith S. Hochman, David F. Kong, Robert M. Califf, Frans Van de Werf, William S. Yancy, and L Kristin Newby. “Elevated body mass index and intermediate-term clinical outcomes after acute coronary syndromes..” Am J Med 118, no. 9 (September 2005): 981–90. https://doi.org/10.1016/j.amjmed.2005.02.017.
    Full Text Link to Item
  - Kong, David F., and Pascal J. Goldschmidt-Clermont. “Tiny solutions for giant cardiac problems..” Trends Cardiovasc Med 15, no. 6 (August 2005): 207–11. https://doi.org/10.1016/j.tcm.2005.07.003.
    Full Text Link to Item
  - Kong, David F., and Eric L. Eisenstein. “Decision models for assessing the cost effectiveness of drug-eluting stents..” Expert Opin Pharmacother 6, no. 6 (June 2005): 965–74. https://doi.org/10.1517/14656566.6.6.965.
    Full Text Link to Item
  - Liao, Lawrence, Antonio Sarria-Santamera, David B. Matchar, Ayn Huntington, Shu Lin, David J. Whellan, and David F. Kong. “Meta-analysis of survival and relief of angina pectoris after transmyocardial revascularization..” Am J Cardiol 95, no. 10 (May 15, 2005): 1243–45. https://doi.org/10.1016/j.amjcard.2005.01.057.
    Full Text Link to Item
  - Cohen, Mauricio G., Robert V. Kelly, David F. Kong, Venu Menon, Monica Shah, Jorge Ferreira, Karen S. Pieper, et al. “Pulmonary artery catheterization in acute coronary syndromes: insights from the GUSTO IIb and GUSTO III trials..” Am J Med 118, no. 5 (May 2005): 482–88. https://doi.org/10.1016/j.amjmed.2004.12.018.
    Full Text Link to Item
  - Kong, D. F. “Drug-eluting stents reduce restenosis rates and major adverse cardiac events, but not mortality, in patients undergoing percutaneous coronary intervention.” Evidence Based Healthcare and Public Health 9, no. 1 (January 1, 2005): 16–19. https://doi.org/10.1016/j.ehbc.2004.11.030.
    Full Text
  - Kong, David F., and Daniel B. Mark. “Economic impact of new interventional therapies: are we asking the right questions?.” J Am Coll Cardiol 44, no. 9 (November 2, 2004): 1809–11. https://doi.org/10.1016/j.jacc.2004.08.010.
    Full Text Link to Item
  - Bittl, John A., Derek P. Chew, Eric J. Topol, David F. Kong, and Robert M. Califf. “Meta-analysis of randomized trials of percutaneous transluminal coronary angioplasty versus atherectomy, cutting balloon atherotomy, or laser angioplasty..” J Am Coll Cardiol 43, no. 6 (March 17, 2004): 936–42. https://doi.org/10.1016/j.jacc.2003.10.039.
    Full Text Link to Item
  - Quinn, Martin J., Herbert D. Aronow, Robert M. Califf, Deepak L. Bhatt, Shelly Sapp, Neal S. Kleiman, Robert A. Harrington, David F. Kong, David E. Kandzari, and Eric J. Topol. “Aspirin dose and six-month outcome after an acute coronary syndrome..” J Am Coll Cardiol 43, no. 6 (March 17, 2004): 972–78. https://doi.org/10.1016/j.jacc.2003.09.059.
    Full Text Link to Item
  - Kandzari, David E., Vic Hasselblad, James E. Tcheng, Gregg W. Stone, Robert M. Califf, Adnan Kastrati, Franz-Josef Neumann, et al. “Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systematic overview of randomized clinical trials..” Am Heart J 147, no. 3 (March 2004): 457–62. https://doi.org/10.1016/j.ahj.2003.08.011.
    Full Text Link to Item
  - Kong, David F., Eric L. Eisenstein, Michael H. Sketch, James P. Zidar, Thomas J. Ryan, Robert A. Harrington, Mark F. Newman, Peter K. Smith, Daniel B. Mark, and Robert M. Califf. “Economic impact of drug-eluting stents on hospital systems: a disease-state model..” Am Heart J 147, no. 3 (March 2004): 449–56. https://doi.org/10.1016/j.ahj.2003.11.005.
    Full Text Link to Item
  - Kong, David F. “Aspirin in cardiovascular disorders. What is the optimum dose?.” Am J Cardiovasc Drugs 4, no. 3 (2004): 151–58. https://doi.org/10.2165/00129784-200404030-00002.
    Full Text Link to Item
  - Kong, David F., Vic Hasselblad, Robert A. Harrington, Harvey D. White, James E. Tcheng, David E. Kandzari, Eric J. Topol, and Robert M. Califf. “Meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions..” Am J Cardiol 92, no. 6 (September 15, 2003): 651–55. https://doi.org/10.1016/s0002-9149(03)00816-6.
    Full Text Link to Item
  - Liao, Lawrence, and David F. Kong. “Angiographic changes in vein grafts: stable surrogate or seductive siren?.” American Heart Journal 145, no. 2 (February 2003): 187–89. https://doi.org/10.1067/mhj.2003.114.
    Full Text
  - Newby, K., R. Cliff, H. White, and D. F. Kong. “Oral glycoprotein IIb/IIIa inhibitors are associated with increased mortality and myocardial infarction in coronary artery disease.” Evidence Based Cardiovascular Medicine 7, no. 1 (January 1, 2003): 8–9. https://doi.org/10.1016/S1361-2611(02)00139-2.
    Full Text
  - Pasquali, Sara K., Vic Hasselblad, Jennifer S. Li, David F. Kong, and Stephen P. Sanders. “Coronary artery pattern and outcome of arterial switch operation for transposition of the great arteries: a meta-analysis..” Circulation 106, no. 20 (November 12, 2002): 2575–80. https://doi.org/10.1161/01.cir.0000036745.19310.bb.
    Full Text Link to Item
  - Kong, David F., Vic Hasselblad, David E. Kandzari, L Kristin Newby, and Robert M. Califf. “Seeking the optimal aspirin dose in acute coronary syndromes..” Am J Cardiol 90, no. 6 (September 15, 2002): 622–25. https://doi.org/10.1016/s0002-9149(02)02566-3.
    Full Text Link to Item
  - Hansen, K. E., D. F. Kong, K. D. Moore, and T. L. Ortel. “Risk factors associated with thrombosis in patients with antiphospholipid antibodies..” J Rheumatol 28, no. 9 (September 2001): 2018–24.
    Link to Item
  - Hasselblad, V., and D. F. Kong. “Statistical methods for comparison to placebo in active-control trials.” Drug Information Journal 35, no. 2 (2001): 435–49.
  - Borges-Neto, S., A. Javaid, L. K. Shaw, D. F. Kong, M. W. Hanson, R. A. Pagnanelli, G. Ravizzini, and R. E. Coleman. “Poststress measurements of left ventricular function with gated perfusion SPECT: comparison with resting measurements by using a same-day perfusion-function protocol..” Radiology 215, no. 2 (May 2000): 529–33. https://doi.org/10.1148/radiology.215.2.r00ma13529.
    Full Text Link to Item
  - Kong, D. F., M. A. Blazing, and C. M. O’Connor. “Advances in the approach to acute coronary syndromes..” Hosp Pract (1995) 35, no. 4 (April 15, 2000): 61–64.
    Link to Item
  - Cohen, M. G., D. F. Kong, J. J. Warner, M. B. Wightman, A. B. Greenbaum, J. E. Tcheng, R. H. Peter, M. H. Sketch, L. H. Muhlbaier, and J. P. Zidar. “Outcomes following interventions in small coronary arteries with the use of hand-crimped Palmaz-Schatz stents..” Am J Cardiol 85, no. 4 (February 15, 2000): 446–50. https://doi.org/10.1016/s0002-9149(99)00770-5.
    Full Text Link to Item
  - Borges-Neto, S., A. Javid, D. Kong, L. Shaw, and R. E. Coleman. “Prediction of myocardial perfusion abnormalities by quantitative regional function using a radionuclide angiography database: a comparison with wall motion analysis..” Clin Nucl Med 25, no. 2 (February 2000): 110–14. https://doi.org/10.1097/00003072-200002000-00006.
    Full Text Link to Item
  - Cohen, M. G., M. P. Hudson, C. B. Granger, D. F. Kong, L. H. Gardner, G. S. Wagner, R. M. Califf, S. Savonitto, and E. J. Topol. “Quantitative electrocardiographic variables predict adverse outcomes in Non-ST elevation acute coronary syndromes: Results from GUSTO IIb.” Journal of the American College of Cardiology 35, no. 2 (February 1, 2000): 410A-411A.
    Link to Item
  - Kong, D. F., E. J. Topol, J. A. Bittl, H. D. White, P. Théroux, V. Hasselblad, and R. M. Califf. “Clinical outcomes of bivalirudin for ischemic heart disease..” Circulation 100, no. 20 (November 16, 1999): 2049–53. https://doi.org/10.1161/01.cir.100.20.2049.
    Full Text Link to Item
  - Cohen, M. G., C. B. Granger, E. M. Ohman, A. L. Stebbins, L. R. Grinfeld, A. M. Cagide, M. V. Elizari, et al. “Outcome of Hispanic patients treated with thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I and III trials. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries..” J Am Coll Cardiol 34, no. 6 (November 15, 1999): 1729–37. https://doi.org/10.1016/s0735-1097(99)00433-7.
    Full Text Link to Item
  - Kong, D. F., and R. M. Califf. “Glycoprotein IIb/IIIa receptor antagonists in non-ST elevation acute coronary syndromes and percutaneous revascularisation: a review of trial reports..” Drugs 58, no. 4 (October 1999): 609–20. https://doi.org/10.2165/00003495-199958040-00003.
    Full Text Link to Item
  - Tcheng, J. E., and D. F. Kong. “Vale, warfarin: a stentorian farewell..” Am Heart J 138, no. 4 Pt 1 (October 1999): 602–5. https://doi.org/10.1016/s0002-8703(99)70169-9.
    Full Text Link to Item
  - Tcheng, J. E., and D. F. Kong. “Vale, warfarin: a stentorian farewell..” American Heart Journal 138, no. 4 Pt 1 (October 1999): 602–5. https://doi.org/10.1016/s0002-8703(99)70169-9.
    Full Text
  - Alexander, J. H., S. Al-Khatib, W. Cantor, A. B. Greenbaum, M. P. Hudson, D. F. Kong, and M. Shah. “Highlights from the American College of Cardiology 48th Annual Scientific Sessions: March 7 to 10, 1999..” Am Heart J 138, no. 1 Pt 1 (July 1999): 175–90. https://doi.org/10.1016/s0002-8703(99)90000-5.
    Full Text Link to Item
  - Kong, D. F. “Steroids for restenosis: strike three!.” Am Heart J 138, no. 1 Pt 1 (July 1999): 3–4. https://doi.org/10.1016/s0002-8703(99)70234-6.
    Full Text Link to Item
  - Kong, D. F., and R. M. Califf. “Coronary interventions "to go": Is faster better?.” J Invasive Cardiol 11, no. 6 (June 1999): 401–2.
    Link to Item
  - Kong, D. F., M. A. Blazing, and C. M. O’Connor. “The health care burden of unstable angina..” Cardiol Clin 17, no. 2 (May 1999): 247–61.
    Link to Item
  - Sadowski, Z. P., J. H. Alexander, B. Skrabucha, A. Dyduszynski, J. Kuch, E. Nartowicz, G. Swiatecka, D. F. Kong, and C. B. Granger. “Multicenter randomized trial and a systematic overview of lidocaine in acute myocardial infarction..” Am Heart J 137, no. 5 (May 1999): 792–98. https://doi.org/10.1016/s0002-8703(99)70401-1.
    Full Text Link to Item
  - Alexander, J. H., D. F. Kong, and W. J. Cantor. “Highlights from the 71st American Heart Association Scientific Sessions: November 8 to 11, 1998..” Am Heart J 137, no. 3 (March 1999): 555–74. https://doi.org/10.1016/s0002-8703(99)70506-5.
    Full Text Link to Item
  - Kong, D. F., R. M. Califf, D. P. Miller, D. J. Moliterno, H. D. White, R. A. Harrington, J. E. Tcheng, A. M. Lincoff, V. Hasselblad, and E. J. Topol. “Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease..” Circulation 98, no. 25 (December 22, 1998): 2829–35. https://doi.org/10.1161/01.cir.98.25.2829.
    Full Text Link to Item
  - Miller, J. M., E. M. Ohman, V. Hasselblad, C. B. Granger, M. H. Sketch, D. F. Kong, and R. M. Califf. “Can TIMI grade 3 flow at 60 minutes after thrombolysis substitute as a new angiographic standard? A meta-analytic approach.” Circulation 98, no. 17 (October 27, 1998): 784–784.
    Link to Item
  - Kong, D. F., and R. M. Califf. “Post-procedure heparin: boon or burden?.” Am Heart J 136, no. 2 (August 1998): 183–85. https://doi.org/10.1053/hj.1998.v136.90239.
    Full Text Link to Item
  - Alexander, J. H., A. B. Greenbaum, M. P. Hudson, D. F. Kong, J. M. Miller, C. Y. Tung, and D. J. Whellan. “Session highlights from the American College of Cardiology Scientific Sessions: March 29 to April 1, 1998..” Am Heart J 136, no. 1 (July 1998): 176–79. https://doi.org/10.1016/s0002-8703(98)70199-1.
    Full Text Link to Item
  - Kong, D. F., and E. D. Peterson. “Squeezing the "value" from cost data..” Am Heart J 136, no. 1 (July 1998): 1–3. https://doi.org/10.1016/s0002-8703(98)70172-3.
    Full Text Link to Item
  - Alexander, J. H., A. B. Greenbaum, M. P. Hudson, D. F. Kong, J. M. Miller, C. Y. Tung, and D. J. Whellan. “Session highlights from the American College of Cardiology Scientific Sessions: March 29 to April 1, 1998..” Am Heart J 135, no. 6 Pt 1 (June 1998): 1099–1114. https://doi.org/10.1016/s0002-8703(98)70079-1.
    Full Text Link to Item
  - Alexander, J. H., K. Alexander, D. F. Kong, C. Y. Tung, and D. Whellan. “Session highlights from the American Heart Association Scientific Sessions: November 9-12, 1997..” Am Heart J 135, no. 1 (January 1998): 157–80. https://doi.org/10.1016/s0002-8703(98)70357-6.
    Full Text Link to Item
  - Kong, D. F., K. L. Lee, F. E. Harrell, J. M. Boswick, D. B. Mark, M. A. Hlatky, R. M. Califf, and D. B. Pryor. “Clinical experience and predicting survival in coronary disease..” Arch Intern Med 149, no. 5 (May 1989): 1177–81.
    Link to Item
  - Wall, T. C., D. B. Mark, R. M. Califf, G. Collins, R. Burgess, T. N. Skelton, T. Hinohara, D. F. Kong, S. Mantell, and L. Aronson. “Prediction of early recurrent myocardial ischemia and coronary reocclusion after successful thrombolysis: a qualitative and quantitative angiographic study..” Am J Cardiol 63, no. 7 (February 15, 1989): 423–28. https://doi.org/10.1016/0002-9149(89)90312-3.
    Full Text Link to Item
- Reports
  - Al-Khatib, S. M., N. Allen LaPointe, R. Chatterjee, M. J. Crowley, M. E. Dupre, D. F. Kong, R. D. Lopes, et al. “Treatment of Atrial Fibrillation. Comparative Effectiveness Review 119.” Treatment of Atrial Fibrillation. Comparative Effectiveness Review 119. Rockville, MD: AHRQ Publication, June 28, 2013.
- Conference Papers
  - Ortel, Thomas L., Ian Welsby, David F. Kong, John A. Heit, Elizabeth Krakow, Nicole Whitlatch, Gowthami M. Arepally, Grace Lee, Shahar Bar-Yosef, and Eliot C. Williams. “HIT Antibody Seropositivity and Thromboembolic Events After Cardiac Surgery.” In Blood, 118:524–25. AMER SOC HEMATOLOGY, 2011.
    Link to Item
  - Eisenstein, Eric L., Patricia A. Cowper, Jay Bae, David F. Kong, and Kevin J. Anstrom. “Assessing proportions of higher-risk acute coronary syndrome-percutaneous coronary intervention patients in clinical trials and clinical practice.” In Circulation, 117:E421–22. LIPPINCOTT WILLIAMS & WILKINS, 2008.
    Link to Item
  - Whitlatch, Nicole L., David F. Kong, and Thomas L. Ortel. “Prediction of heparin induced thrombocytopenia: Validation of an experience-based computer model.” In Blood, 110:947A-947A. AMER SOC HEMATOLOGY, 2007.
    Link to Item
  - Eisenstein, Eric L., Robert M. Tuttle, Linda K. Shaw, Kevin J. Anstrom, and David F. Kong. “Drug-eluting stent use is associated with significant improvements in long-term clinical outcomes.” In Circulation, 114:863–863. LIPPINCOTT WILLIAMS & WILKINS, 2006.
    Link to Item
  - Liao, L., D. F. Kong, Z. Samad, P. A. Pappas, J. G. Jollis, S. S. Lin, A. Wang, et al. “Echocardiographic risk-stratification for early surgery in patients with endocarditis is a cost-attractive alternative to standard care.” In Journal of the American College of Cardiology, 47:280A-280A. ELSEVIER SCIENCE INC, 2006.
    Link to Item
  - Liao, L., J. H. Alexander, D. F. Kong, M. H. Sketch, P. A. Pappas, J. Zhou, S. S. Lin, L. K. Shaw, K. J. Anstrom, and D. B. Mark. “Which patients with previous bypass surgery benefit most from repeat revascularization?.” In Journal of the American College of Cardiology, 47:203A-203A. ELSEVIER SCIENCE INC, 2006.
    Link to Item
  - Hsu, G. W., G. Wagner, and D. F. Kong. “Comparison of two clinical decision-making tools in the management of cardiovascular disease.” In Circulation, 112:U641–U641. LIPPINCOTT WILLIAMS & WILKINS, 2005.
    Link to Item
  - Kachhy, R. G., D. F. Kong, E. Honeycutt, L. K. Shaw, and R. D. Davis. “Long-term outcomes of the symmetry vein graft anastamosis device: A matched case-control analysis.” In Circulation, 112:U432–33. LIPPINCOTT WILLIAMS & WILKINS, 2005.
    Link to Item
  - Liao, L., A. Sarria-Santamera, A. Huntington, D. J. Whellan, D. B. Matchar, and D. F. Kong. “Meta-analysis of survival and angina relief after transmyocardial revascularization.” In Journal of the American College of Cardiology, 45:357A-357A. ELSEVIER SCIENCE INC, 2005.
    Link to Item
  - Eisenstein, E. L., D. K. McGuire, M. V. Bhapkar, D. F. Kong, R. M. Califf, and L. K. Newby. “Moderate obesity is associated with better intermediate-term survival in acute coronary syndromes: Results from the SYMPHONY and 2nd SYMPHONY clinical trials.” In Journal of the American College of Cardiology, 41:387A-387A. ELSEVIER SCIENCE INC, 2003.
    Link to Item
  - KONG, D. “P2856 Cumulative meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions.” In European Heart Journal, 24:544–544. Elsevier BV, 2003. https://doi.org/10.1016/s0195-668x(03)95634-x.
    Full Text
  - Liao, L., D. F. Kong, L. K. Shaw, M. H. Sketch, C. A. Milano, and D. B. Mark. “A statistical tool for predicting survival after bypass surgery: The Duke graft index.” In Circulation, 106:413–413. LIPPINCOTT WILLIAMS & WILKINS, 2002.
    Link to Item
  - Pasquali, S. K., V. Hasselblad, J. S. Li, D. F. Kong, and S. P. Sanders. “Coronary artery pattern and mortality following arterial switch operation for transposition of the great arteries: A meta-analysis.” In Circulation, 106:717–18. LIPPINCOTT WILLIAMS & WILKINS, 2002.
    Link to Item
  - Kong, D. F., L. K. Shaw, F. E. Harrell, L. H. Muhlbaler, K. L. Lee, R. M. Califf, and R. H. Jones. “Predicting survival from the coronary arteriogram: An experience-based statistical index of coronary artery disease severity.” In Journal of the American College of Cardiology, 39:327A-327A. ELSEVIER SCIENCE INC, 2002.
    Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

Duke Appointment History

Selected Grants

Industry Relationships

Selected Publications

Academic Articles

Reports

Conference Papers